Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictors: measurements by using dynamic MRI spin-lattice relaxometry

J Magn Reson Imaging. 2008 Apr;27(4):846-53. doi: 10.1002/jmri.21324.

Abstract

Purpose: To improve the outcome prediction of uterine cervical carcinoma by measuring the vascular permeability (k(ep)) and the extracellular volume fraction (v(e)) of the tumor from Dynamic T(1)- IRM Relaxometry.

Materials and methods: Twenty-six patients with proven cervical carcinoma were divided into good outcome and poor outcome groups. Classic tumor prognostic factors, the longest diameter L and the volume V of the tumor, were measured from morphologic MR images. The tumor parameters k(ep) and v(e) were determined from the relaxometry time-curve acquired during the contrast uptake after a bolus intravenous injection of an extracellular contrast agent.

Results: All "small" tumors (L<35 mm or V<11 cm(3)) were good outcome with 100% sensitivity but a rather low specificity (36% and 43% for L and V, respectively). With regard to the physiopathological parameter k(ep), "large" tumors (L >or= 35 mm) can also be classified as good outcome on the condition that k(ep) >or= 2.2 min(-1) with 100% sensitivity and 89% specificity. Regarding the extracellular volume fraction (v(e)), no significant difference was observed between the two groups.

Conclusion: Measurement of the tumor vascular permeability might be useful to predict prognostic, to evaluate the treatment efficacy, and to adapt a proper therapy schedule.

MeSH terms

  • Adult
  • Aged
  • Capillary Permeability*
  • Carcinoma / blood supply*
  • Carcinoma / pathology
  • Carcinoma / therapy
  • Contrast Media
  • Disease-Free Survival
  • Extracellular Space*
  • Female
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Middle Aged
  • Prognosis
  • Sensitivity and Specificity
  • Tumor Burden
  • Uterine Cervical Neoplasms / blood supply*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / therapy

Substances

  • Contrast Media
  • Gadolinium DTPA